Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 129 Colonic Neoplasms 54 Rectal Neoplasms 48 Carcinoma, Hepatocellular 29 Stomach Neoplasms 23 Neoplasm Metastasis 23 Neoplasms 11 Pancreatic Neoplasms 10 Cholangiocarcinoma 9 Adenocarcinoma Of Esophagus 8 Esophageal Neoplasms 7 Liver Neoplasms 6 Gastrointestinal Neoplasms 5 Biliary Tract Neoplasms 5 Recurrence 4 Ovarian Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Squamous Cell Carcinoma 3 Digestive System Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Unresectable Metastatic Colorectal Cancer 2 Peritoneal Neoplasms 2 Neurotoxicity Syndromes 2 Neoplastic Cells, Circulating 2 Intestinal Neoplasms 2 Gastrointestinal Diseases 2 Gallbladder Neoplasms 2 Colorectal Cancer Metastatic 2 Cirrhosis, Familial, with Pulmonary Hypertension 2

Interventions

Microscopy, Confocal 2 Indocyanine Green 2 Everolimus 2 Dermoscopy 2 varlilumab 1 Ultrasonography 1 Tumor Burden 1 Sunitinib 1 Simvastatin 1 Radiosurgery 1 Palliative Care 1 Observation 1 Neoadjuvant Therapy 1 Narrow Band Imaging 1 Mastectomy, Segmental 1 Interferon alpha-2 1 IFL protocol 1 Gastrectomy 1 Folfox protocol 1 Esophagectomy 1 Endoscopic Mucosal Resection 1 Drug Delivery Systems 1 Drug Combinations 1 Chemoradiotherapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Margins of Excision × Folfox protocol × Clear all

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡